Greg Brown
InvestorAdvisory Board - Healthcare Royalty Investing Pioneer at FemHealth Ventures
About
Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Aquestive Therapeutics, Inc.Caladrius Biosciences, Inc.Faron Pharmaceuticals OyFAST BioMedicalMemgen, Inc
Per the firm's website.
